INFINITT PACS System Alternatives, What INFINITT PACS Costs and What to Switch To

The short answer: INFINITT PACS is the radiology PACS from INFINITT Healthcare, a Seoul company listed on KOSDAQ, sold in the US by INFINITT North America in Phillipsburg, New Jersey. INFINITT publishes no price. The only public US price points are three federal awards from one Bureau of Prisons medical center: $186,326 for a PACS with installation in 2019, then $14,500 and $16,909 for software and upgrades. The alternatives most often quoted against it are Intelerad, RamSoft and Sectra, or keeping INFINITT and adding AI to the read.

Company facts come from INFINITT press releases, KRX and Korean financial press. FDA data is from the openFDA 510(k) and recall databases. Federal award figures are from USAspending.gov, award types A to D, fiscal 2008 to 2026, pulled September 29, 2026, with every recipient name and description read by hand.

Who owns INFINITT Healthcare?

INFINITT Healthcare is a public company on the Korean KOSDAQ exchange under ticker 071200, listed since May 2010. Its largest shareholder since 2002 has been Solbon, which held about 47 to 49 percent directly and more than half counting related parties as of December 2025. The business began in 1997 as Mediface, the PACS research unit of the ultrasound maker Medison, merged with 3DMed in 2002 and took the INFINITT Healthcare name in September 2009. The US subsidiary, INFINITT North America, was set up in 2005.

Two things a US buyer should know. First, Solbon tried to sell its controlling stake in 2012 through Merrill Lynch and then withdrew, so a change of control has been on the table before. Second, on October 17, 2025 the Korea Exchange halted trading in INFINITT shares and opened a listing review after a former co-CEO was found to have committed breach of trust worth KRW 3.78 billion. The exchange decided to keep the listing and trading resumed on January 21, 2026. Neither event touches the software, but both belong in your vendor risk file, and a multi-year PACS contract should carry a change-of-control clause and a data export commitment whatever the vendor.

If your board wants to hear about that kind of event before the account manager calls, simple news monitoring on the vendor's name catches filings and trade press as they appear, including the Korean coverage that broke the trading halt.

How much does INFINITT PACS cost?

INFINITT does not publish a price, and the Capterra listing shows a one-dollar placeholder rather than a real figure. The only checkable US numbers come from the federal record, and there are exactly three of them, all from the US Medical Center for Federal Prisoners in Springfield, Missouri.

That is $217,735 in total. Three awards to one buyer cannot tell you what your system will cost, but the shape is useful. A single-site hospital PACS with installation came in under $200,000 through a competed purchase with eight bidders, and the follow-on software and upgrade orders ran $14,500 to $17,000 each, sole source. The pattern to price for is a moderate entry cost followed by recurring upgrade orders you cannot put out to bid, because only the incumbent can upgrade its own system.

For context, federal awards for other PACS vendors put INFINITT at the low end. Fujifilm Synapse shows 202 awards with a $64,615 median, Intelerad 20 awards worth $32.3 million, almost all of it VA teleradiology, and Merge 136 awards with a $16,988 median, mostly cardiology. The wider benchmark on PACS pricing and cloud PACS cost works through what those figures mean for an imaging center quote.

What should an INFINITT PACS quote itemize?

Ask for these as separate lines, because a single bundled number hides the parts that grow:

• Software license or subscription, and whether it is priced per study, per concurrent user or per site.
• Hardware, if you take the turnkey option, and who owns and refreshes it.
• Installation, interfaces to your RIS and EHR, and the migration of prior studies from your current archive.
• Annual maintenance as a percentage, and the cap on its yearly increase.
• Version upgrades: included in maintenance, or quoted separately like the Springfield orders.
• Modules you may add later, such as Mammo, Cardiology, RT PACS or digital pathology, priced now rather than at the time you need them.
• Data export at exit in standard DICOM, at no charge, with a stated timeline.

INFINITT PACS vs Intelerad, RamSoft and Sectra

The honest reading: INFINITT tends to win when a hospital wants one vendor across radiology, cardiology and increasingly pathology, and the 2026 Best in KLAS award for its cardiology suite backs that up. It has no open recalls in the FDA database, which is more than some larger vendors can say. Where it is weaker is the public record in the US, which is thin, so ask for three reference sites your size, ideally imaging centers or teleradiology groups such as the Inspire Radiology rollout announced in November 2023. If you are also looking at RamSoft, RamSoft PACS alternatives covers PowerServer and OmegaAI the same way, and the Sectra PACS system and Sectra One cost covers the enterprise end.

Is INFINITT PACS FDA cleared?

Yes. INFINITT holds 17 FDA 510(k) clearances between 2003 and 2025, all but one under product code LLZ for image processing systems. The current PACS clearance is K172803 for INFINITT PACS 7.0, decided October 27, 2017. Others cover Cardiology PACS (K082706, 2008), RT PACS (K193498, 2020) and the INFINITT digital pathology system (K243449, December 2025). Ask which clearance covers the version you are quoted.

When does switching away from INFINITT make sense?

Switch when the PACS itself is the problem: the viewer is slow on large CT and MR studies, support response is not meeting your turnaround needs, or the vendor cannot give you a roadmap and a reference site that matches your size. A PACS migration is a months-long project with priors migration, new interfaces, new hanging protocols and retraining every reader, so it should fix something the current system cannot.

Do not switch because radiologists want AI in the read. That is the most common reason a PACS evaluation starts, and it is the one that does not need a new PACS.

Can I add AI to INFINITT PACS without replacing it?

Yes. An AI assistant that works over standard DICOM receives studies from the PACS you already run, INFINITT included, flags suspected findings, moves the urgent studies up the worklist and drafts a structured report for the radiologist to edit and sign. Radiologists keep reading in the INFINITT viewer. The setup is a DICOM route and a worklist connection, measured in days to weeks rather than the months of a migration.

That is what Radiological.ai does. It is decision support, the radiologist signs every report, and pricing is published per reading radiologist on our pricing page: $399 a month on the Practice plan or $199 a month billed annually, and $598 a month on the Group plan or $299 a month billed annually. For the details of what connects to what, see how the assistant integrates with your PACS. If your shortlist is really about choosing a PACS, PACS software compared separates the deployment models and Intelerad PACS alternatives covers the vendor most often quoted against INFINITT.

What are the alternatives to INFINITT PACS?

The PACS most often quoted against INFINITT in the US are Intelerad IntelePACS, now owned by GE HealthCare, RamSoft PowerServer and OmegaAI, Sectra, Fujifilm Synapse and Merge. Imaging centers and teleradiology groups tend to shortlist Intelerad and RamSoft; hospitals add Sectra and Synapse. The other alternative is to keep INFINITT and add an AI assistant that reads from it.